Azacitidine in Combination with Venetoclax Maintenance Post-allogeneic Hematopoietic Stem Cell Transplantation in T Cell Acute Lymphoblastic Leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2590-0048
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Azacitidine in Combination with Venetoclax Maintenance Post-allogeneic Hematopoietic Stem Cell Transplantation in T Cell Acute Lymphoblastic Leukemia ; day:3 ; month:1 ; year:2023 ; pages:1-4
Clinical hematology international ; (3.1.2023), 1-4
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s44228-022-00019-1
- URN
-
urn:nbn:de:101:1-2023031909133460466473
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hassan, Mona Ali
- Moukalled, Nour
- El Cheikh, Jean
- Bazarbachi, Ali
- Abou Dalle, Iman
- SpringerLink (Online service)
Ähnliche Objekte (12)
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome
Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation
Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation
Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation
Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia; Current Evidence, and Improving Outcomes Going Forward
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome
Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation
Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation
Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation
Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia; Current Evidence, and Improving Outcomes Going Forward
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome
Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation
Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation
Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation
Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia; Current Evidence, and Improving Outcomes Going Forward